The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells

Abstract Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its high genetic heterogeneity. In search of novel putative therapeutic RNA targets we investigated the role of the oncogenic long noncoding RNA LINC00152 (CYTOR, and STAiR18) in A172 glioblastoma cells....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stefanie Binder, Ivonne Zipfel, Claudia Müller, Karolin Wiedemann, Carolin Schimmelpfennig, Gabriele Pfeifer, Kristin Reiche, Sunna Hauschildt, Jörg Lehmann, Ulrike Köhl, Friedemann Horn, Maik Friedrich
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f6aa5d7c6fd84bb49a2909a2f8daa5fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f6aa5d7c6fd84bb49a2909a2f8daa5fa
record_format dspace
spelling oai:doaj.org-article:f6aa5d7c6fd84bb49a2909a2f8daa5fa2021-12-02T18:02:15ZThe noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells10.1038/s41598-021-97533-82045-2322https://doaj.org/article/f6aa5d7c6fd84bb49a2909a2f8daa5fa2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97533-8https://doaj.org/toc/2045-2322Abstract Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its high genetic heterogeneity. In search of novel putative therapeutic RNA targets we investigated the role of the oncogenic long noncoding RNA LINC00152 (CYTOR, and STAiR18) in A172 glioblastoma cells. Here, we are the first to describe, that LINC00152 unexpectedly acts in a tumor suppressive manner in this cell line. SiRNA-based knockdown of LINC00152 enhanced malignant tumor behaviors including proliferation, cell cycle entry, migration, and invasion, contradicting previous studies using U87-MG and LN229 glioblastoma cells. Furthermore, LINC00152 knockdown had no influence on survival of A172 glioblastoma cells. In a genome wide transcription analysis of A172 and U87-MG glioblastoma cells, we identified 70 LINC00152 target genes involved in locomotion, cell migration, and motility in A172 cells, whereas in U87-MG cells only 40 target genes were detected. The LINC00152-regulated genes found in A172 differed from those identified in U87-MG glioblastoma cells, none of them being regulated in both cell lines. These findings underline the strong genetic heterogeneity of glioblastoma and point to a potential, yet unknown risk addressing LINC00152 lncRNA as a prospective therapeutic target in GBM.Stefanie BinderIvonne ZipfelClaudia MüllerKarolin WiedemannCarolin SchimmelpfennigGabriele PfeiferKristin ReicheSunna HauschildtJörg LehmannUlrike KöhlFriedemann HornMaik FriedrichNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Stefanie Binder
Ivonne Zipfel
Claudia Müller
Karolin Wiedemann
Carolin Schimmelpfennig
Gabriele Pfeifer
Kristin Reiche
Sunna Hauschildt
Jörg Lehmann
Ulrike Köhl
Friedemann Horn
Maik Friedrich
The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
description Abstract Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its high genetic heterogeneity. In search of novel putative therapeutic RNA targets we investigated the role of the oncogenic long noncoding RNA LINC00152 (CYTOR, and STAiR18) in A172 glioblastoma cells. Here, we are the first to describe, that LINC00152 unexpectedly acts in a tumor suppressive manner in this cell line. SiRNA-based knockdown of LINC00152 enhanced malignant tumor behaviors including proliferation, cell cycle entry, migration, and invasion, contradicting previous studies using U87-MG and LN229 glioblastoma cells. Furthermore, LINC00152 knockdown had no influence on survival of A172 glioblastoma cells. In a genome wide transcription analysis of A172 and U87-MG glioblastoma cells, we identified 70 LINC00152 target genes involved in locomotion, cell migration, and motility in A172 cells, whereas in U87-MG cells only 40 target genes were detected. The LINC00152-regulated genes found in A172 differed from those identified in U87-MG glioblastoma cells, none of them being regulated in both cell lines. These findings underline the strong genetic heterogeneity of glioblastoma and point to a potential, yet unknown risk addressing LINC00152 lncRNA as a prospective therapeutic target in GBM.
format article
author Stefanie Binder
Ivonne Zipfel
Claudia Müller
Karolin Wiedemann
Carolin Schimmelpfennig
Gabriele Pfeifer
Kristin Reiche
Sunna Hauschildt
Jörg Lehmann
Ulrike Köhl
Friedemann Horn
Maik Friedrich
author_facet Stefanie Binder
Ivonne Zipfel
Claudia Müller
Karolin Wiedemann
Carolin Schimmelpfennig
Gabriele Pfeifer
Kristin Reiche
Sunna Hauschildt
Jörg Lehmann
Ulrike Köhl
Friedemann Horn
Maik Friedrich
author_sort Stefanie Binder
title The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
title_short The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
title_full The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
title_fullStr The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
title_full_unstemmed The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
title_sort noncoding rna linc00152 conveys contradicting effects in different glioblastoma cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f6aa5d7c6fd84bb49a2909a2f8daa5fa
work_keys_str_mv AT stefaniebinder thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT ivonnezipfel thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT claudiamuller thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT karolinwiedemann thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT carolinschimmelpfennig thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT gabrielepfeifer thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT kristinreiche thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT sunnahauschildt thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT jorglehmann thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT ulrikekohl thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT friedemannhorn thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT maikfriedrich thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT stefaniebinder noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT ivonnezipfel noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT claudiamuller noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT karolinwiedemann noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT carolinschimmelpfennig noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT gabrielepfeifer noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT kristinreiche noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT sunnahauschildt noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT jorglehmann noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT ulrikekohl noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT friedemannhorn noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
AT maikfriedrich noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells
_version_ 1718378963978420224